All In Biotech

Free tool

FAERS Monitor: Anafranil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019906 or its brand name (Anafranil, Clomipramine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,574

Serious

4,205

92% of reports

Hospitalization

2,459

Death reported

402

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction234
  • somnolence217
  • fall209
  • off label use200
  • tremor189
  • nausea182
  • coma180
  • suicide attempt177
  • intentional overdose176
  • drug ineffective173
  • anxiety167
  • confusional state166
  • malaise152
  • asthenia151
  • fatigue148

Reports by year received

View as table
YearReports
2004168
2005121
2006118
2007139
2008156
2009153
2010161
2011192
2012180
2013169
2014199
2015221
2016257
2017261
2018290
2019304
2020291
2021190
2022206
2023248
2024210
2025169
2026170

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,585 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
comaSignal18017.415.12,770
suicide attemptSignal17713.511.62,029
intentional overdoseSignal17612.710.91,877
drug interactionSignal2346.86.01,157
tremorSignal1895.24.6649
somnolenceSignal2175.04.4688
confusional stateSignal1664.74.1487
fallSignal2092.92.5260
anxietySignal1672.72.3179
asthenia1511.81.659
malaise1521.61.434
nausea1821.10.91
off label use2001.10.90
fatigue1480.90.73
drug ineffective1730.60.548

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.